tiprankstipranks
Trending News
More News >
Towa Pharmaceutical Co (JP:4553)
:4553
Japanese Market
Advertisement

Towa Pharmaceutical Co (4553) Ratios

Compare
0 Followers

Towa Pharmaceutical Co Ratios

JP:4553's free cash flow for Q1 2026 was ¥0.36. For the 2026 fiscal year, JP:4553's free cash flow was decreased by ¥ and operating cash flow was ¥0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.82 2.72 2.72 2.33 1.45
Quick Ratio
1.56 1.46 1.46 1.15 0.82
Cash Ratio
0.39 0.37 0.37 0.31 0.29
Solvency Ratio
0.12 0.12 0.12 0.09 0.14
Operating Cash Flow Ratio
0.39 0.10 0.10 0.03 0.19
Short-Term Operating Cash Flow Coverage
1.26 0.62 0.62 0.11 0.34
Net Current Asset Value
¥ -49.75B¥ -57.04B¥ -57.04B¥ -51.46B¥ -30.90B
Leverage Ratios
Debt-to-Assets Ratio
0.50 0.47 0.47 0.47 0.44
Debt-to-Equity Ratio
1.38 1.30 1.30 1.26 1.09
Debt-to-Capital Ratio
0.58 0.56 0.56 0.56 0.52
Long-Term Debt-to-Capital Ratio
0.53 0.55 0.55 0.52 0.37
Financial Leverage Ratio
2.75 2.76 2.76 2.71 2.50
Debt Service Coverage Ratio
1.42 1.92 1.92 0.96 0.36
Interest Coverage Ratio
12.41 18.63 18.63 8.68 83.50
Debt to Market Cap
1.56 1.45 1.45 1.86 1.07
Interest Debt Per Share
4.87K 4.13K 4.13K 3.53K 2.93K
Net Debt to EBITDA
4.22 4.86 4.86 5.97 3.77
Profitability Margins
Gross Profit Margin
36.26%35.70%35.70%34.81%42.38%
EBIT Margin
12.32%7.74%7.74%2.51%11.19%
EBITDA Margin
18.35%15.59%15.59%11.93%17.81%
Operating Profit Margin
8.69%7.74%7.74%2.64%11.60%
Pretax Profit Margin
8.28%10.73%10.73%2.20%13.43%
Net Profit Margin
6.10%7.10%7.10%1.05%9.61%
Continuous Operations Profit Margin
6.10%7.10%7.10%1.05%9.61%
Net Income Per EBT
73.73%66.12%66.12%47.80%71.54%
EBT Per EBIT
95.30%138.60%138.60%83.51%115.83%
Return on Assets (ROA)
3.37%3.76%3.76%0.59%4.82%
Return on Equity (ROE)
9.52%10.37%10.37%1.61%12.04%
Return on Capital Employed (ROCE)
5.91%5.03%5.03%1.88%8.94%
Return on Invested Capital (ROIC)
4.05%3.21%3.21%0.84%4.91%
Return on Tangible Assets
3.72%4.26%4.26%0.69%5.77%
Earnings Yield
11.02%11.61%11.61%2.36%11.77%
Efficiency Ratios
Receivables Turnover
4.46 3.18 3.18 3.84 3.26
Payables Turnover
9.09 5.56 5.56 4.35 5.60
Inventory Turnover
1.48 1.45 1.45 1.47 1.31
Fixed Asset Turnover
1.55 1.48 1.48 1.64 1.64
Asset Turnover
0.55 0.53 0.53 0.56 0.50
Working Capital Turnover Ratio
1.63 1.88 1.88 2.67 2.41
Cash Conversion Cycle
287.83 300.80 300.80 260.32 324.73
Days of Sales Outstanding
81.80 114.75 114.75 95.05 111.84
Days of Inventory Outstanding
246.17 251.73 251.73 249.13 278.07
Days of Payables Outstanding
40.14 65.68 65.68 83.87 65.18
Operating Cycle
327.97 366.48 366.48 344.19 389.91
Cash Flow Ratios
Operating Cash Flow Per Share
714.75 166.84 166.84 51.68 449.63
Free Cash Flow Per Share
67.26 -632.11 -632.11 -567.33 173.79
CapEx Per Share
647.49 798.96 798.96 619.01 275.85
Free Cash Flow to Operating Cash Flow
0.09 -3.79 -3.79 -10.98 0.39
Dividend Paid and CapEx Coverage Ratio
1.00 0.19 0.19 0.08 1.38
Capital Expenditure Coverage Ratio
1.10 0.21 0.21 0.08 1.63
Operating Cash Flow Coverage Ratio
0.15 0.04 0.04 0.01 0.15
Operating Cash Flow to Sales Ratio
0.13 0.04 0.04 0.01 0.13
Free Cash Flow Yield
2.28%-22.34%-22.34%-29.94%6.32%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
8.98 8.61 8.61 42.38 8.50
Price-to-Sales (P/S) Ratio
0.55 0.61 0.61 0.45 0.82
Price-to-Book (P/B) Ratio
0.83 0.89 0.89 0.68 1.02
Price-to-Free Cash Flow (P/FCF) Ratio
43.41 -4.48 -4.48 -3.34 15.81
Price-to-Operating Cash Flow Ratio
4.09 16.96 16.96 36.66 6.11
Price-to-Earnings Growth (PEG) Ratio
-0.57 0.01 0.01 -0.49 0.61
Price-to-Fair Value
0.83 0.89 0.89 0.68 1.02
Enterprise Value Multiple
7.21 8.78 8.78 9.71 8.36
Enterprise Value
348.10B 312.00B 312.00B 242.08B 246.54B
EV to EBITDA
7.24 8.78 8.78 9.71 8.36
EV to Sales
1.33 1.37 1.37 1.16 1.49
EV to Free Cash Flow
105.13 -10.03 -10.03 -8.67 28.83
EV to Operating Cash Flow
9.89 37.99 37.99 95.16 11.14
Tangible Book Value Per Share
2.60K 2.14K 2.14K 1.71K 1.59K
Shareholders’ Equity Per Share
3.51K 3.17K 3.17K 2.78K 2.69K
Tax and Other Ratios
Effective Tax Rate
0.26 0.34 0.34 0.52 0.28
Revenue Per Share
5.33K 4.63K 4.63K 4.24K 3.37K
Net Income Per Share
325.11 328.58 328.58 44.72 323.35
Tax Burden
0.74 0.66 0.66 0.48 0.72
Interest Burden
0.67 1.39 1.39 0.88 1.20
Research & Development to Revenue
0.06 0.06 0.06 0.07 0.07
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
2.20 0.51 0.51 0.55 0.99
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis